Identity
- Security key
- 13267
- Ticker
- CELU
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-07-19
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CELU
Detail
Enriched 2026-08-14 20:47
- Market cap
- $19,972,713.09
- Shares outstanding (class)
- 28,945,961
- Shares outstanding (weighted)
- 28,945,961
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 115
- Location
- FLORHAM PARK, NJ
- Homepage
- https://www.celularity.com
- Description
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.